Balance Sheet
Cash Flow Statement
AmortizationAmortizationCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Free Cash Flow (2016 - 2025)

MediWound has reported Free Cash Flow over the past 13 years, most recently at -$11.6 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 13.48% year-over-year to -$11.6 million; the TTM value through Dec 2025 reached -$21.6 million, down 8.69%, while the annual FY2025 figure was -$21.6 million, 8.69% down from the prior year.
  • Free Cash Flow for Q4 2025 was -$11.6 million at MediWound, down from -$2.2 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at $2.2 million in Q1 2023 and troughed at -$13.4 million in Q4 2024.
  • A 5-year average of -$4.1 million and a median of -$3.2 million in 2024 define the central range for Free Cash Flow.
  • On a YoY basis, Free Cash Flow climbed as much as 155.24% in 2023 and fell as far as 7068.82% in 2023.
  • Year by year, Free Cash Flow stood at -$2.1 million in 2021, then soared by 91.22% to -$186000.0 in 2022, then tumbled by 7068.82% to -$13.3 million in 2023, then fell by 0.32% to -$13.4 million in 2024, then grew by 13.48% to -$11.6 million in 2025.
  • Business Quant data shows Free Cash Flow for MDWD at -$11.6 million in Q4 2025, -$2.2 million in Q3 2025, and -$4.7 million in Q2 2025.